Molecular epidemiologic studies have presented seemingly contradictory results concerning a potential role of CTSD polymorphism in Alzheimer s disease (6 to 19). There is also controversy on whether this polymorphism may interact with the apolipoprotein E 4 allele (APOE*4), which is the best known genetic determinant for sporadic Alzhei-mer s disease (20)
